Danielle Keatley
Investor Relations Contact chez STRUCTURE THERAPEUTICS INC.
Postes actifs de Danielle Keatley
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Investor Relations Contact | - | - |
Historique de carrière de Danielle Keatley
Anciens postes connus de Danielle Keatley
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Investor Relations Contact | 01/02/2016 | 01/08/2021 |
| Public Communications Contact | 01/02/2016 | 01/08/2021 | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Public Communications Contact | - | - |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Public Communications Contact | 2 |
| Investor Relations Contact | 2 |
Sectorielle
| Health Technology | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Bourse
- Insiders
- Danielle Keatley
- Expérience
